Themes guiding the analysis | Key questions | Data collection methods |
---|---|---|
Process data on GBV screening | How many women were screened for GBV? How many experienced GBV? How many women were referred? | â–ªGBV screening outcome forms |
Fidelity | How has GBV screening been delivered? How much of the GBV screening was delivered as intended? • What parts were not delivered? • Challenges to delivery? | ▪In-depth interviews with study clinical staff ▪Observations of GBV screening sessions ▪Notes from debriefing meetings with counsellors |
Feasibility | What were barriers and facilitators to GBV screening? | â–ªIn-depth interviews with study participants and study clinical staff â–ªNotes from debriefing meetings with counsellors |
Acceptability and participants’ response | What are young women’s views and perceptions of the GBV screening? How did young women respond to GBV screening? What are study clinical staff’s perceptions of GBV screening? | ▪In-depth interviews with study clinical staff and study participants |
Unintended/unanticipated consequences | Were there any side-effects/unintended consequences when delivering GBV screening? (i.e. on the study participants or study clinical staff) | â–ªIn-depth interviews with study clinical staff and with study participants â–ªNotes from debriefing meetings with counsellors |